
Respiratory Medicine Updates: A Virtual Clinical Community
Our Next Session is July 12-13, 2022 • CME Credit for Zoom Webinar and Twitter Chat Participants
Article: The impact of disease severity measures on survival in U.S. Veterans with rheumatoid arthritis-associated interstitial lung disease, Rheumatology, 2022, keac208, https://doi.org/10.1093/rheumatology/keac208
 |
|
|
 |
- Zoom Webinar with CME credit: REGISTER.
- Tuesday, July 12, 2022
- 11:30 am (PT) / 12:30 pm (MT) / 1:30 pm (CT) / 2:30 pm (ET)
- 30-minutes
- Expert faculty summarize a journal article and lead an academic and peer discussion with Q&A time.
|
|
 |
- Twitter Chat @NJHealthMedEd with CME credit: Add to Calendar
- Wednesday, July 13, 2022
- 6:00 pm (PT) / 7:00 pm (MT) / 8:00 pm (CT) / 9:00 pm (ET)
- 30-minutes
- Expert faculty lead the Chat about the article summary to facilitate an academic and peer discussion with Q&A.
- Go to Twitter, type in #ILDTwitterJC and click on the “Latest” tab
- Please use this hashtag when posting: #ILDTwitterJC
- Twitter Chat Instructions
- Follow us on Twitter @NJHealthMedEd
|
Previous ILD Journal Club Sessions:
 |
- June 14-15, 2022
- June 2022 Article Summary: Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis. N Engl J Med. 2022 May 15. doi: 10.1056/NEJMoa2201737. Epub ahead of print. PMID: 35569036. View here.
- Recorded Zoom Webinar on VuMedi.
|
|
- May 10-11, 2022
- May 2022 Article Summary: The Role of Genetic Testing in Pulmonary Fibrosis: A Perspective From the Pulmonary Fibrosis Foundation Genetic Testing Work Group, Chest, 2022, ISSN 0012-3692, https://doi.org/10.1016/j.chest.2022.03.023. View here.
- Recorded Zoom Webinar on VuMedi.
|
|
- April 19-20, 2022
- April 2022 Article Summary: Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease. Respir Med. 2019 Jul-Aug;154:6-11. doi: 10.1016/j.rmed.2019.05.012. Epub 2019 May 21. PMID: 31176796. View here.
- Recorded Zoom Webinar on VuMedi.
|
|
- March 8-9, 2022
- March 2022 Article Summary: Diagnostic Accuracy of Endobronchial Optical Coherence Tomography for the Microscopic Diagnosis of Usual Interstitial Pneumonia. Am J Respir Crit Care Med. 2021 Nov 15;204(10):1164-1179. doi: 10.1164/rccm.202104-0847OC. PMID: 34375171. View here.
- Recorded Zoom Webinar on VuMedi.
|
|
- February 8-9, 2022
- February 2022 Article Summary: Leukocyte Telomere Length and Mycophenolate Therapy in Chronic Hypersensitivity Pneumonitis. Eur Respir J. 2021 Mar 4;57(3):2002872. doi: 10.1183/13993003.02872-2020. Print 2021 Mar. View here.
- Recorded Zoom Webinar on VuMedi.
|
|
- December 14-15, 2021
- December 2021 Article Summary: Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N Engl J Med 2019; 381:1718-1727 DOI: 10.1056/NEJMoa1908681. View here.
- Recorded Zoom Webinar on VuMedi.
|
|
- November 9-10, 2021
- November 2021 Article Summary: Avacopan for the Treatment of ANCA-Associated Vasculitis. N Engl J Med 2021;384:599-609. DOI: 10.1056/NEJMoa2023386. View here.
- Recorded Zoom Webinar on VuMedi.
|
|
- October 12-13, 2021
- October 2021 Article Summary: Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia. Am J Respir Crit Care Med. 2021 Jan 15;203(2):211-220. doi: 10.1164/rccm.202003-0877OC. View here.
- Recorded Zoom Webinar on VuMedi.
|
|
- September 14, 2021
- September 2021 Article Summary: Tocilizumab in systemic sclerosis: a randomized, double-blind, placebo-controlled, phase 3 trial. The Lancet Respiratory Medicine. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. View here.
- Recorded Zoom Webinar on VuMedi.
|
|
- August 10-11, 2021
- August 2021 Article Summary: Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomized controlled trial, The Lancet Respiratory Medicine. 2018;6(10):759-770. View here.
- Recorded Zoom Webinar on VuMedi.
|
Target Audience:
Pulmonologists, Rheumatologists, Radiologists, Pathologists, Dermatologists, Primary Care Physicians, Physician Assistants, and Nurse Practitioners.
Program Chair:
 |
Matthew Koslow, MD
Assistant Professor
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
National Jewish Health, Denver, CO
|
Learning Objectives:
Upon completion of this activity, the participant will be better able to:
- Apply critical thinking and research analysis in the review of research and guidelines in ILD
- Utilize increased awareness and understanding of research, evidence and best practices to inform clinical practice in ILD
- Support an online community of practitioners to share key insights, latest research, and treatment strategies for patients with ILD
Contact:
For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email proed@njhealth.org.
Accreditation and Designation Statements:
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Webinars
National Jewish Health designates each live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Twitter Chat Sessions
National Jewish Health designates each Other activity (social media discussion) for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support:
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.